US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 4.9500
  • +0.3400+7.38%
Close Dec 16 16:00 ET
  • 5.1267
  • +0.1767+3.57%
Post 20:01 ET
23.93MMarket Cap-0.99P/E (TTM)

Vivos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-49.54%-4.19M
-6.61%-3.05M
28.91%-2.52M
39.01%-11.95M
8.40%-2.75M
52.07%-2.8M
38.69%-2.86M
41.81%-3.54M
-24.48%-19.59M
27.22%-3M
Net income from continuing operations
-25.04%-2.62M
65.10%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.93%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Operating gains losses
100.34%6K
-98.67%14K
100.24%6K
-487.07%-3.04M
-16.22%217K
-1,858.00%-1.76M
532.53%1.05M
-144.49%-2.55M
-323.28%-518K
--259K
Depreciation and amortization
-2.01%146K
-2.03%145K
-16.57%146K
-7.17%621K
-11.83%149K
-15.34%149K
-47.70%148K
326.83%175K
-8.73%669K
0.60%169K
Other non cash items
--0
----
----
--87K
----
----
----
----
----
----
Change In working capital
-361.43%-1.86M
-254.05%-1.56M
244.21%802K
67.39%2.86M
-51.96%906K
168.96%713K
-16.84%1.01M
165.08%233K
6,010.71%1.71M
8.64%1.89M
-Change in receivables
-159.60%-59K
2,283.33%131K
-338.24%-324K
-65.82%255K
-93.64%26K
233.78%99K
-102.86%-6K
-32.34%136K
227.19%746K
-84.45%409K
-Change in prepaid assets
-125.49%-78K
-115.38%-42K
-19.89%145K
729.09%912K
-77.25%152K
646.43%306K
56.00%273K
126.74%181K
111.59%110K
2,374.07%668K
-Change in payables and accrued expense
-597.61%-1.04M
-402.48%-809K
333.93%486K
356.89%1.16M
111.91%996K
118.25%209K
-5.92%-161K
-70.29%112K
-135.83%-450K
-12.96%470K
-Change in other current liabilities
-129.63%-32K
-104.66%-55K
83.93%-9K
662.91%1.15M
30.77%-81K
89.47%108K
413.48%1.18M
-194.74%-56K
--151K
40.31%-117K
-Change in other working capital
-7,177.78%-655K
-185.09%-784K
460.00%504K
-152.95%-611K
-141.01%-187K
-104.89%-9K
-136.47%-275K
41.67%-140K
327.61%1.15M
136.05%456K
Cash from discontinued investing activities
Operating cash flow
-49.54%-4.19M
-6.61%-3.05M
28.91%-2.52M
39.01%-11.95M
8.40%-2.75M
52.07%-2.8M
38.69%-2.86M
41.81%-3.54M
-24.48%-19.59M
27.22%-3M
Investing cash flow
Cash flow from continuing investing activities
-24.68%-192K
75.51%-60K
47.75%-151K
7.68%-853K
17.50%-165K
-54.00%-154K
51.39%-245K
-140.83%-289K
64.57%-924K
47.64%-200K
Net PPE purchase and sale
-24.68%-192K
75.51%-60K
36.82%-151K
13.10%-803K
17.50%-165K
-54.00%-154K
51.39%-245K
-99.17%-239K
61.44%-924K
47.64%-200K
Net other investing changes
----
----
----
---50K
--0
--0
--0
---50K
----
----
Cash from discontinued investing activities
Investing cash flow
-24.68%-192K
75.51%-60K
47.75%-151K
7.68%-853K
17.50%-165K
-54.00%-154K
51.39%-245K
-140.83%-289K
64.57%-924K
47.64%-200K
Financing cash flow
Cash flow from continuing financing activities
3.79M
7.4M
-50.58%3.64M
10.92M
3.57M
0
0
7.36M
0
0
Net common stock issuance
----
----
----
--12M
--12M
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--7.5M
-50.74%3.94M
----
----
--0
--0
--8M
----
----
Net other financing activities
---509K
---100K
52.56%-306K
---1.08M
---432K
--0
--0
---645K
----
----
Cash from discontinued financing activities
Financing cash flow
--3.79M
--7.4M
-50.58%3.64M
--10.92M
--3.57M
--0
--0
--7.36M
--0
--0
Net cash flow
Beginning cash position
75.11%6.9M
-62.94%2.61M
-53.31%1.64M
-85.36%3.52M
-85.30%988K
-68.87%3.94M
-60.48%7.05M
-85.36%3.52M
31.99%24.03M
-76.45%6.72M
Current changes in cash
79.96%-592K
238.27%4.29M
-72.55%968K
90.85%-1.88M
120.47%655K
50.29%-2.95M
39.93%-3.1M
156.87%3.53M
-452.18%-20.51M
28.95%-3.2M
End cash Position
538.77%6.31M
75.11%6.9M
-62.94%2.61M
-53.31%1.64M
-53.31%1.64M
-85.30%988K
-68.87%3.94M
-60.48%7.05M
-85.36%3.52M
-85.36%3.52M
Free cash flow
-48.24%-4.38M
-0.13%-3.11M
29.41%-2.67M
37.84%-12.75M
8.97%-2.91M
50.29%-2.95M
39.93%-3.1M
39.08%-3.78M
-13.13%-20.51M
28.95%-3.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -49.54%-4.19M-6.61%-3.05M28.91%-2.52M39.01%-11.95M8.40%-2.75M52.07%-2.8M38.69%-2.86M41.81%-3.54M-24.48%-19.59M27.22%-3M
Net income from continuing operations -25.04%-2.62M65.10%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.93%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Operating gains losses 100.34%6K-98.67%14K100.24%6K-487.07%-3.04M-16.22%217K-1,858.00%-1.76M532.53%1.05M-144.49%-2.55M-323.28%-518K--259K
Depreciation and amortization -2.01%146K-2.03%145K-16.57%146K-7.17%621K-11.83%149K-15.34%149K-47.70%148K326.83%175K-8.73%669K0.60%169K
Other non cash items --0----------87K------------------------
Change In working capital -361.43%-1.86M-254.05%-1.56M244.21%802K67.39%2.86M-51.96%906K168.96%713K-16.84%1.01M165.08%233K6,010.71%1.71M8.64%1.89M
-Change in receivables -159.60%-59K2,283.33%131K-338.24%-324K-65.82%255K-93.64%26K233.78%99K-102.86%-6K-32.34%136K227.19%746K-84.45%409K
-Change in prepaid assets -125.49%-78K-115.38%-42K-19.89%145K729.09%912K-77.25%152K646.43%306K56.00%273K126.74%181K111.59%110K2,374.07%668K
-Change in payables and accrued expense -597.61%-1.04M-402.48%-809K333.93%486K356.89%1.16M111.91%996K118.25%209K-5.92%-161K-70.29%112K-135.83%-450K-12.96%470K
-Change in other current liabilities -129.63%-32K-104.66%-55K83.93%-9K662.91%1.15M30.77%-81K89.47%108K413.48%1.18M-194.74%-56K--151K40.31%-117K
-Change in other working capital -7,177.78%-655K-185.09%-784K460.00%504K-152.95%-611K-141.01%-187K-104.89%-9K-136.47%-275K41.67%-140K327.61%1.15M136.05%456K
Cash from discontinued investing activities
Operating cash flow -49.54%-4.19M-6.61%-3.05M28.91%-2.52M39.01%-11.95M8.40%-2.75M52.07%-2.8M38.69%-2.86M41.81%-3.54M-24.48%-19.59M27.22%-3M
Investing cash flow
Cash flow from continuing investing activities -24.68%-192K75.51%-60K47.75%-151K7.68%-853K17.50%-165K-54.00%-154K51.39%-245K-140.83%-289K64.57%-924K47.64%-200K
Net PPE purchase and sale -24.68%-192K75.51%-60K36.82%-151K13.10%-803K17.50%-165K-54.00%-154K51.39%-245K-99.17%-239K61.44%-924K47.64%-200K
Net other investing changes ---------------50K--0--0--0---50K--------
Cash from discontinued investing activities
Investing cash flow -24.68%-192K75.51%-60K47.75%-151K7.68%-853K17.50%-165K-54.00%-154K51.39%-245K-140.83%-289K64.57%-924K47.64%-200K
Financing cash flow
Cash flow from continuing financing activities 3.79M7.4M-50.58%3.64M10.92M3.57M007.36M00
Net common stock issuance --------------12M--12M--------------0--0
Proceeds from stock option exercised by employees --0--7.5M-50.74%3.94M----------0--0--8M--------
Net other financing activities ---509K---100K52.56%-306K---1.08M---432K--0--0---645K--------
Cash from discontinued financing activities
Financing cash flow --3.79M--7.4M-50.58%3.64M--10.92M--3.57M--0--0--7.36M--0--0
Net cash flow
Beginning cash position 75.11%6.9M-62.94%2.61M-53.31%1.64M-85.36%3.52M-85.30%988K-68.87%3.94M-60.48%7.05M-85.36%3.52M31.99%24.03M-76.45%6.72M
Current changes in cash 79.96%-592K238.27%4.29M-72.55%968K90.85%-1.88M120.47%655K50.29%-2.95M39.93%-3.1M156.87%3.53M-452.18%-20.51M28.95%-3.2M
End cash Position 538.77%6.31M75.11%6.9M-62.94%2.61M-53.31%1.64M-53.31%1.64M-85.30%988K-68.87%3.94M-60.48%7.05M-85.36%3.52M-85.36%3.52M
Free cash flow -48.24%-4.38M-0.13%-3.11M29.41%-2.67M37.84%-12.75M8.97%-2.91M50.29%-2.95M39.93%-3.1M39.08%-3.78M-13.13%-20.51M28.95%-3.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data